We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Glanbia Plc | LSE:GLB | London | Ordinary Share | IE0000669501 | ORD EUR0.06 (CDI) |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.01 | -0.06% | 17.92 | 17.34 | 18.50 | 37,777 | 16:35:27 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 5.43B | 344.5M | 1.2652 | 14.95 | 5.15B |
TIDMGLB
RNS Number : 2575B
Glanbia PLC
03 April 2017
Completion of acquisition of Body & Fit
3(rd) April 2017
Further to its announcement on 06 February 2017, Glanbia plc, the global nutrition group, today confirms that it has now completed the acquisition of B&F Vastgoed B.V. ("Body & Fit"). The completion conditions having been satisfied and regulatory approvals obtained.
ENDS
For further information contact
Glanbia plc +353 56 777 2200
Investor contact: Liam Hennigan, Head of Investor Relations: +353 86 046 8375 Media Contact: Mark Garrett, Director of Communications & Public Affairs: +353 86 601 9655
This information is provided by RNS
The company news service from the London Stock Exchange
END
ACQJBMFTMBJJBMR
(END) Dow Jones Newswires
April 03, 2017 02:00 ET (06:00 GMT)
1 Year Glanbia Chart |
1 Month Glanbia Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions